FAKTOR OPTIONSSCHEIN - MERCK & CO. | Real-time Boerse Frankfurt Warrants 13:00:17 2024-06-04 EDT | ||
| 2.46 EUR | -3.15% |
|
| Current month | -13.90% | ||
| 1 month | -6.62% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-06-04 | 2.46 | -3.15% |
| 24-06-03 | 2.54 | -13.90% |
| 24-05-31 | 2.95 | +13.90% |
| 24-05-30 | 2.59 | -8.80% |
| 24-05-29 | 2.84 | +1.43% |
Real-time Boerse Frankfurt Warrants
Last update June 04, 2024 at 01:00 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | MERCK & CO., INC. |
| Issuer | UBS |
| WKN | UM0LRP |
| ISIN | DE000UM0LRP8 |
| Date issued | 2024-01-16 |
| Strike | 149.8 $ |
| Maturity | Unlimited |
| Parity | 7.86 : 1 |
| Emission price | 5.07 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 5.55 € |
|---|---|
| Lowest since issue | 2.09 € |
| Spread | 0.05 € |
| Spread % | 2.02% |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
128.4
USD
Average target price
142.2
USD
Spread / Average Target
+10.73%
- Stock Market
- Certificates
- Certificat
